• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞色素P450同工酶介导的药物-药物相互作用的计算机模拟预测

In Silico Prediction of Drug-Drug Interactions Mediated by Cytochrome P450 Isoforms.

作者信息

Dmitriev Alexander V, Rudik Anastassia V, Karasev Dmitry A, Pogodin Pavel V, Lagunin Alexey A, Filimonov Dmitry A, Poroikov Vladimir V

机构信息

Laboratory of Structure-Function Based Drug Design, Department of Bioinformatics, Institute of Biomedical Chemistry, Pogodinskaya Str. 10, bldg. 8, 119121 Moscow, Russia.

出版信息

Pharmaceutics. 2021 Apr 13;13(4):538. doi: 10.3390/pharmaceutics13040538.

DOI:10.3390/pharmaceutics13040538
PMID:33924315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8068971/
Abstract

Drug-drug interactions (DDIs) can cause drug toxicities, reduced pharmacological effects, and adverse drug reactions. Studies aiming to determine the possible DDIs for an investigational drug are part of the drug discovery and development process and include an assessment of the DDIs potential mediated by inhibition or induction of the most important drug-metabolizing cytochrome P450 isoforms. Our study was dedicated to creating a computer model for prediction of the DDIs mediated by the seven most important P450 cytochromes: CYP1A2, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, and CYP3A4. For the creation of structure-activity relationship (SAR) models that predict metabolism-mediated DDIs for pairs of molecules, we applied the Prediction of Activity Spectra for Substances (PASS) software and Pairs of Substances Multilevel Neighborhoods of Atoms (PoSMNA) descriptors calculated based on structural formulas. About 2500 records on DDIs mediated by these cytochromes were used as a training set. Prediction can be carried out both for known drugs and for new, not-yet-synthesized substances. The average accuracy of the prediction of DDIs mediated by various isoforms of cytochrome P450 estimated by leave-one-out cross-validation (LOO CV) procedures was about 0.92. The SAR models created are publicly available as a web resource and provide predictions of DDIs mediated by the most important cytochromes P450.

摘要

药物相互作用(DDIs)可导致药物毒性、药理作用减弱以及药物不良反应。旨在确定研究药物可能存在的药物相互作用的研究是药物发现和开发过程的一部分,包括评估由最重要的药物代谢细胞色素P450同工酶的抑制或诱导介导的药物相互作用潜力。我们的研究致力于创建一个计算机模型,用于预测由七种最重要的P450细胞色素介导的药物相互作用:CYP1A2、CYP2B6、CYP2C19、CYP2C8、CYP2C9、CYP2D6和CYP3A4。为了创建预测分子对代谢介导的药物相互作用的构效关系(SAR)模型,我们应用了物质活性谱预测(PASS)软件和基于结构式计算的物质原子对多级邻域(PoSMNA)描述符。大约2500条关于这些细胞色素介导的药物相互作用的记录用作训练集。预测既可以针对已知药物,也可以针对尚未合成的新物质进行。通过留一法交叉验证(LOO CV)程序估计的细胞色素P450各种同工酶介导的药物相互作用预测的平均准确率约为0.92。创建的SAR模型作为网络资源公开可用,并提供由最重要的细胞色素P450介导的药物相互作用的预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8259/8068971/7b03517af752/pharmaceutics-13-00538-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8259/8068971/39021c4e17f8/pharmaceutics-13-00538-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8259/8068971/7b03517af752/pharmaceutics-13-00538-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8259/8068971/39021c4e17f8/pharmaceutics-13-00538-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8259/8068971/7b03517af752/pharmaceutics-13-00538-g002.jpg

相似文献

1
In Silico Prediction of Drug-Drug Interactions Mediated by Cytochrome P450 Isoforms.细胞色素P450同工酶介导的药物-药物相互作用的计算机模拟预测
Pharmaceutics. 2021 Apr 13;13(4):538. doi: 10.3390/pharmaceutics13040538.
2
ZY12201, A Potent TGR5 Agonist: Identification of a Novel Pan CYP450 Inhibitor Tool Compound for In-Vitro Assessment.ZY12201,一种强效的TGR5激动剂:用于体外评估的新型泛CYP450抑制剂工具化合物的鉴定。
Drug Metab Lett. 2022 Mar 15. doi: 10.2174/1872312815666220315145945.
3
Pre-clinical drug-drug interactions (DDIs) of gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine.吉非替尼与/不与氯沙坦及选择性5-羟色胺再摄取抑制剂(SSRI)的临床前药物相互作用(DDI):西酞普兰、氟西汀、氟伏沙明、帕罗西汀、舍曲林和文拉法辛。
Curr Res Pharmacol Drug Discov. 2022 Jun 14;3:100112. doi: 10.1016/j.crphar.2022.100112. eCollection 2022.
4
..
Drug Metab Dispos. 2024 Feb 26;52(5):DMD-AR-2024-001660. doi: 10.1124/dmd.124.001660.
5
QSAR Modeling and Prediction of Drug-Drug Interactions.药物相互作用的定量构效关系建模与预测
Mol Pharm. 2016 Feb 1;13(2):545-56. doi: 10.1021/acs.molpharmaceut.5b00762. Epub 2016 Jan 5.
6
Drug-drug interaction prediction using PASS.基于 PASS 的药物-药物相互作用预测。
SAR QSAR Environ Res. 2019 Sep;30(9):655-664. doi: 10.1080/1062936X.2019.1653966. Epub 2019 Sep 4.
7
Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization.大麻素与细胞色素P450药物代谢的相互作用:全谱表征
AAPS J. 2021 Jun 28;23(4):91. doi: 10.1208/s12248-021-00616-7.
8
Metabolism site prediction based on xenobiotic structural formulas and PASS prediction algorithm.基于外源化学物结构式和 PASS 预测算法的代谢部位预测。
J Chem Inf Model. 2014 Feb 24;54(2):498-507. doi: 10.1021/ci400472j. Epub 2014 Jan 17.
9
Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.通过细胞色素450抑制试验评估Synacinn™与个体生物标志物的药草-药物相互作用。
Drug Metab Lett. 2018;12(1):62-67. doi: 10.2174/1872312812666180314112457.
10
Cytochrome-P450-Mediated DrugDrug Interactions of Substrate Drugs: Assessing Clinical Risk Based on Molecular Properties and an Extended Clearance Classification System.细胞色素 P450 介导的底物药物的药物药物相互作用:基于分子特性和扩展的清除分类系统评估临床风险。
Mol Pharm. 2020 Aug 3;17(8):3024-3032. doi: 10.1021/acs.molpharmaceut.0c00444. Epub 2020 Jul 7.

引用本文的文献

1
Delineating CYP2C19-mediated Interactions: Network Pharmacology Investigation of Ilaprazole and Clopidogrel Conventional Proton Pump Inhibitors.描述CYP2C19介导的相互作用:伊拉普利唑与氯吡格雷及传统质子泵抑制剂的网络药理学研究
Curr Drug Discov Technol. 2025;22(3):e15701638334244. doi: 10.2174/0115701638334244241224062453.
2
Oxidative Stress Induced by Antivirals: Implications for Adverse Outcomes During Pregnancy and in Newborns.抗病毒药物诱导的氧化应激:对妊娠及新生儿不良结局的影响
Antioxidants (Basel). 2024 Dec 12;13(12):1518. doi: 10.3390/antiox13121518.
3
DoE-assisted HPLC method development and validation of enzalutamide and repaglinide in rat plasma.

本文引用的文献

1
SuperCYPsPred-a web server for the prediction of cytochrome activity.SuperCYPsPred——一个用于预测细胞色素活性的网络服务器。
Nucleic Acids Res. 2020 Jul 2;48(W1):W580-W585. doi: 10.1093/nar/gkaa166.
2
Prediction of Severity of Drug-Drug Interactions Caused by Enzyme Inhibition and Activation.预测由酶抑制和激活引起的药物相互作用的严重程度。
Molecules. 2019 Oct 31;24(21):3955. doi: 10.3390/molecules24213955.
3
Drug-drug interaction prediction using PASS.基于 PASS 的药物-药物相互作用预测。
基于实验设计(DoE)的 HPLC 方法开发与验证:用于大鼠血浆中恩扎卢胺和瑞格列奈的检测。
Bioanalysis. 2024;16(17-18):931-945. doi: 10.1080/17576180.2024.2383070. Epub 2024 Aug 8.
4
Computational drug-drug interaction prediction mediated by CYP450 isoforms of Ilaprazole coadministered with clopidogrel.由伊拉普利与氯吡格雷共同给药时CYP450同工型介导的药物-药物相互作用的计算预测。
Future Sci OA. 2024 May 20;10(1):FSO966. doi: 10.2144/fsoa-2023-0277. eCollection 2024.
5
Utility of sustainable ratio derivative spectrophotometry for the concurrent assay of synergistic repurposed drugs for COVID-19 infections; Insilico pharmacokinetics proof.可持续比率导数分光光度法用于同时测定 COVID-19 感染协同性重新利用药物的效用;计算机模拟药代动力学验证。
BMC Chem. 2024 Mar 7;18(1):50. doi: 10.1186/s13065-024-01147-w.
6
Machine learning to predict metabolic drug interactions related to cytochrome P450 isozymes.用于预测与细胞色素P450同工酶相关的代谢性药物相互作用的机器学习
J Cheminform. 2022 Apr 15;14(1):23. doi: 10.1186/s13321-022-00602-x.
SAR QSAR Environ Res. 2019 Sep;30(9):655-664. doi: 10.1080/1062936X.2019.1653966. Epub 2019 Sep 4.
4
Prediction of Drug-Drug Interactions Related to Inhibition or Induction of Drug-Metabolizing Enzymes.预测与药物代谢酶抑制或诱导相关的药物-药物相互作用。
Curr Top Med Chem. 2019;19(5):319-336. doi: 10.2174/1568026619666190123160406.
5
A combinatorial approach for the discovery of cytochrome P450 2D6 inhibitors from nature.从自然界中发现细胞色素 P450 2D6 抑制剂的组合方法。
Sci Rep. 2017 Aug 14;7(1):8071. doi: 10.1038/s41598-017-08404-0.
6
Computational prediction of drug-drug interactions based on drugs functional similarities.基于药物功能相似性的药物相互作用的计算预测
J Biomed Inform. 2017 Jun;70:54-64. doi: 10.1016/j.jbi.2017.04.021. Epub 2017 Apr 30.
7
Predicting drug-drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge.通过药物结构相似性以及整合药代动力学和药效学知识的相互作用网络来预测药物-药物相互作用。
J Cheminform. 2017 Mar 7;9:16. doi: 10.1186/s13321-017-0200-8. eCollection 2017.
8
In Silico Prediction of hPXR Activators Using Structure-Based Pharmacophore Modeling.基于结构的药效团模型对人孕烷X受体激活剂的计算机模拟预测
J Pharm Sci. 2017 Jul;106(7):1752-1759. doi: 10.1016/j.xphs.2017.03.004. Epub 2017 Mar 16.
9
In Silico Predictions of Drug - Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition - a Comparative Study of Virtual Screening Performance.由CYP1A2、2C9和3A4抑制引起的药物-药物相互作用的计算机模拟预测——虚拟筛选性能的比较研究
Mol Inform. 2015 Jun;34(6-7):431-57. doi: 10.1002/minf.201400192. Epub 2015 Jun 23.
10
Label Propagation Prediction of Drug-Drug Interactions Based on Clinical Side Effects.基于临床副作用的药物-药物相互作用的标签传播预测
Sci Rep. 2015 Jul 21;5:12339. doi: 10.1038/srep12339.